Cellectis SA (CLLS)
1.61
+0.02
(+1.26%)
USD |
NASDAQ |
Dec 20, 16:00
1.58
-0.03
(-1.86%)
After-Hours: 20:00
Cellectis Profit Margin (Quarterly): -142.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Edap TMS SA | -48.85% |
| DBV Technologies SA | -- |
| Genfit SA | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.78% |
| Return on Assets | -24.83% |
| Return on Invested Capital | -57.78% |
| Operating Margin (Quarterly) | -66.49% |
| Return on Net Operating Assets | -43.66% |